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Man had always tried to regulate births through various means involving the use of one or more actions such as medications, 
agents, sexual practices, or surgical procedures to prevent conception or pregnancy. The existing birth control methods 
include traditional and modern. The traditional methods are celibacy or sexual abstinence and withdrawal or coitus interruptus 
while the modern methods include male and female condoms, spermicide, contraceptives, sponge, diaphragm, pills, and 
vasectomy. Research has shown that hormonal approach to male contraception may be effective, reversible, and even 
safe. Efforts are ongoing to develop newer male contraceptives that will allow men to become full partners in the prevention 
of unintended pregnancy. This work reviews existing methods of birth control including current researches in birth control 
especially in the male.
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Introduction
Birth control involves one or more actions, devices, sexual 
practices, or medications to intentionally prevent or 
reduce the likelihood of pregnancy or childbirth.[1,2] While 
contraception is the use of various devices, drugs, agents, 
sexual practices, or surgical procedures to prevent conception 
or pregnancy. In this present age, contraceptive use helps 
couples and individuals realize their basic right to decide 
freely and responsibly if and when they want to have a baby.[2,3] 
When considering the global impact, a staggeringly large 
percentage of global pregnancies (40%) are unintended.[4] 
This is in part due to the worldwide variation of access to 
healthcare and contraception, as well as the differing needs 
for contraceptives that are not met by the current market.
The growing use of contraceptive methods has resulted in 
not only improvements in health-related outcomes such 
as reduced maternal mortality and infant mortality[5,6] but 
also improvements in schooling and economic outcomes, 
especially for girls and women.[7] Contraceptives are also 
prescribed for reasons unrelated to sexual activity such 
as in the treatment of acne or in regulating menstrual 
periods.[8] At present, contraception methods available to 
men include condoms, withdrawal, spermicides, periodic 
abstinence (or rhythm) and vasectomy.[1,9] Efforts are 
also ongoing to develop newer male contraceptives to 
allow men to become full partners in the prevention of 
unintended pregnancy. This work reviewed the existing 
methods of contraception and the current status of 
research into the development of novel approaches to 
male fertility control.
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Types of Contraception
Traditional control methods involve the following
a. Celibacy or sexual abstinence-This means avoiding 
penis-in-vagina intercourse to prevent pregnancy
b. Withdrawal (coitus interruptus)-When the man is about 
to have an orgasm, he pulls his penis out of the vagina. 
The ejaculation occurs outside the vagina. The idea 
behind this method is that no sperm will be deposited 
in the vagina. This method is about 90% effective if used 
correctly. However, about one-third of the couples that 
uses this method experiences an accidental pregnancy 
within 12 months.[2]
Modern birth control methods
This involves birth control methods used in the female and 
male.
In the female
a. Female condom – It is made up of polyurethane having 
a flexible ring at each end. One end is secured behind 
the pubic bone to hold the condom in place, while the 
other ring stays outside the vagina[2,3]
b. Spermicides – This is placed in the vagina before 
intercourse to create a chemical barrier.[1,10] It may be 
used alone or in combination with a physical barrier
c. Contraceptive sponge – The contraceptive sponge has 
a depression to hold it in place over the cervix. Foam is 
placed into the vagina using an applicator. The sponge 
acts as a barrier which stops the sperm from reaching 
the egg and also acts as a spermicide[3]
d. Diaphragm – It is a rubber dome-shaped device placed 
over the cervix and fits into place behind the woman’s 
pubic bone with a firm flexible ring that presses it against 
the vaginal walls.[10] The diaphragm is a very effective 
contraceptive device when combined with a spermicide
e. Cervical cap – The cervical cap is a thimble-shaped latex 
rubber barrier device fitted over the cervix and blocks 
sperm from entering the uterus through the external 
orifice of the uterus, called the os.[1] The cap stays in 
place by suction
f. The Lea contraceptive – Is a soft pliable cup-shaped bowl 
with a loop inserted into the vagina before intercourse 
and it prevents sperm from entering the cervix. For 
effectiveness, it must be used with a spermicide and left 
in place for 8 h[3]
g. The pill – Is a combined contraceptive pills having two 
hormones – an estrogen and progestin that stops the 
release of egg (ovulation), and also make the lining of 
the uterus thinner[12]
h. Contraceptive patch – Is a transdermal patch applied to 
the skin that releases synthetic estrogen and progestin 
hormones. The “Patch” is worn each week for 3 
consecutive weeks, generally on the lower abdomen 
or buttocks. The fourth week is patch-free. Moreover, 
it has been shown to be as effective as a combined oral 
contraceptive pill
i. Contraceptive vaginal ring (NuvaRing) – It is the 
trade name for a combined hormonal contraceptive 
vaginal ring manufactured by Organon. It’s a flexible 
plastic (ethylene-vinyl acetate copolymer) ring that 
releases a low dose of a progestin and an estrogen 
over 3 weeks. The NuvaRing is inserted into the vagina 
for a 3-week period, and then removed for one week, 
during which a menstrual period will be experienced[12]
j. Contraceptive injection (The Shot) – The brand 
name is Depo-Provera. Depot medroxyprogesterone 
acetate (DMPA) is a progestin-only long-acting reversible 
hormonal contraceptive birth control drug injected every 
3 months.[1] It stops the woman from releasing an egg 
and provides other contraceptive effects
k. Implants – Implanon (made by Organon International) 
is a rod with a core of progestin (etonogestrel) inserted 
under the skin of the upper arm of a woman.[13] The 
progestin is released slowly and is effective for 3 years
l. Emergency contraception (emergency postcoital 
contraception) – This refers to contraceptive measures 
that, if taken after sex, may prevent pregnancy. They 
are referred to as emergency contraceptives or the 
morning-after pill. These drugs prevent ovulation or 
fertilization and possible postfertilization implantation 
of a blastocyst (embryo). As an emergency contraceptive 
pill, it is different from medical abortion methods[10,13]
m. Intrauterine devices (IUD) – Also known as a coil. It 
is a small, flexible T-shaped device that is placed in 
the uterus by a physician. It stays in place throughout 
the time pregnancy is not desired and is used as a 
primary contraception method but may be used as 
emergency contraception.[11,15] An IUD can last from 5 
to 10 years depending on the type. As an emergency 
contraception, it is intended for occasional use when 
primary contraception means fails and acts before 
implantation.[10] However, as the egg may have already 
been fertilized, some see this as a potential abortifacient 
i.e., a substance that induces abortion[13]
n. Tubal ligation – Is a permanent form of female 
sterilization. The fallopian tubes are severed and 
sealed (pinched shut) to prevent fertilization.[13]
Male contraception
Given the nature of sperm production, a male contraceptive 
can work in any of the two ways, the hormonal methods (sperm 
production) or nonhormonal means such as physical 
barriers (preventing sperm from reaching the egg).
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Nonhormonal Means Such as Physical Barriers
Male condom
This device is a mechanical barrier that looks like long, thin 
deflated balloons made of polyurethane or latex. It is placed 
over the penis before sexual intercourse begins and is used 
to prevent pregnancy by stopping sperm from entering the 
vagina.[14] Apart from preventing pregnancy, they are also 
useful in protecting sexual partners from sexually transmitted 
infections including human immunodeficiency virus.[14] 
Since 1920, most condoms have been made of latex rubber 
and are mostly free from adverse side effects. Improper or 
inconsistent usage of condoms, such as breakage, reduces 
marginally its contraceptive efficacy. Pregnancy rates for 
couples using condoms as their sole means of contraception 
approach 15%–20% per year.[15] A drawback to condoms is their 
poor long-term compliance because they must be used. Apart 
from its being used 100% correctly during sexual encounters, 
other drawbacks includes the dislike of condoms by some 
men because they feel that condoms either diminish sexual 
pleasure or are difficult to used, and finally, some men and 
women develop allergic reactions such as skin irritation, and 
rarely, anaphylaxis to the latex.[16,17] Condoms are by far the 
most commonly used male contraceptives; however, they are 
inelegant and contain usability barriers that make them an 
imperfect solution.[18]
Vasectomy
This refers to surgical procedure designed to make a man 
sterile. The vas deferens (the tubes through which sperm 
pass) are cut or blocked.[14] It is a safe, simple, outpatient 
surgery performed under local anesthesia in which the 
ductus deferens is severed and the ends ligated through a 
small scrotal incision. Vasectomy is highly effective with a 
failure rate of <1% and a low incidence of complications, so 
it appears to be safe regarding overall male health and[19,20] 
other techniques, such as “no-scalpel technique”, are a single 
puncture made midline in the scrotal raphe with scissors, 
are assessed to be superior to older techniques.[21,22] The 
drawbacks to vasectomy include a delay in the onset of 
azoospermia, pain, and rarely, an infection of the surgical site. 
Vasectomies are most appropriate for men who no longer 
wish to father children. Vasectomy reversal, a procedure 
termed vasovasostomy, has the potential to restore fertility 
with pregnancy rates varying from 30% to 70% depending 
on the length of time between vasectomy and the reversal 
procedure. In 20%–30% of men, vasovasostomy is unable 
to restore patency of the vas if more than 8 years have 
elapsed since the original vasectomy.[23] As documented by 
imaging techniques, 20%–40% of men remain infertile despite 
restored patency of the vas possibly due to the presence of 
antisperm antibodies.[24] Even though vasectomy is sometimes 
reversible, the likelihood of an abundance of abnormal 
sperm is high, resulting in lower fertility. The higher rates 
of aneuploidy and diploidy in the sperm cells may increase 
the rate of birth defects.[14]
Intra vas device
The intra vas device (IVD) is a set of tiny implants that block 
the flow of sperm. There are two IVD designs in clinical 
trials. One is a pair of soft, silicone plugs made by the 
Shepherd Medical Company in the United States. The other 
is a urethane tube lined with a tiny nylon sieve made by the 
Foshan Medical Company in China. Both of these designs 
were inspired by the 1980s work of Dr. Lourens Zaneveld, who 
showed in pilot studies that the IVD is a safe and effective 
method of male contraception. The US design of the device 
is made in several sizes and comes with a patented insertion 
tool.[25]
Adjudin
Adjudin is a compound that functions as a contraceptive by 
disrupting the adhesion of spermatids to sertoli cells, causing 
premature spermiation and infertility.[26,27] Administration 
of two doses of 50 mg/kg of adjudin (one dose per week) 
induced 100% infertility 5 weeks after treatment in adult 
rats with fertility rebounding by week 11. Due to the fact 
that there was some liver inflammation observed in a 29-day 
study of adjudin administration, researchers conjugated 
adjudin to an FSHβ  mutant specifically targeting it to sertoli 
cells, thereby significantly reducing the dose necessary for 
contraception. Unfortunately, the cost of this approach 
and the possibility of developing anti-follicle stimulating 
hormone (FSH) autoantibodies is a concern that needs to be 
addressed as the compound progresses to human studies.
Gamendazole
Gamendazole is an indazole carboxylic acid derived from 
lonidamine shown to reduce fertility in male rats without 
affecting testosterone levels in rats. It is a novel drug 
candidate for male contraception that works by impairing the 
function of the apical ectoplasmic specialization. All male rats 
who received a single oral dose of gamendazole at 6 mg/kg 
were infertile, but only 57% regained fertility.[28]
Retinoic acid inhibition
Nutritional studies in rats and genetic studies in mice 
demonstrates a requirement for vitamin A and its metabolites 
at puberty for initiation of spermatogenesis and in adults for 
maintenance of spermatogenesis.[29,30] In the seminiferous 
tubules, both germ and sertoli cells synthesize retinoic acid 
from retinal via aldehyde dehydrogenases. Retinoic acid binds 
one of several retinoic acid receptors (RARs), which regulate 
gene expression. It has been demonstrated that male RAR 
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knockout animals are sterile due to various problems in 
spermatogenesis.[31,32] The blockade of retinoic acid function 
or synthesis has the potential to inhibit spermatogenesis and 
is an appealing approach to male non-hormonal contraceptive 
development.
BMS-189453
BMS-189453 is an orally active retinoic acid receptor 
antagonist. At daily oral doses of 15, 60, or 240 mg/kg 
for 1 month, BMS-189453 produced marked testicular 
degeneration in rats, but also led to increases in leukocyte 
counts, alkaline phosphatase and alanine aminotransferase 
levels.[33] But in another study in mice, it was explored 
whether a lower dose of BMS-189453 might function as a 
contraceptive without the toxicity seen at higher doses.[34] 
The study showed that the mice were completely sterile 
by 4 weeks after a dosing regimen of 5 mg/kg and by the 
end of treatment with a dose of 2.5 mg/kg for 4 weeks. 
Hematology and serum chemistry analysis were unaffected 
by BMS-189453 administration. This compound, or a more 
specific retinoic acid-alpha antagonists hold promise for 
non-hormonal contraception.[35]
WIN 18,446
Over 50 years ago, the oral administration of WIN 18,446 
was shown to safely, completely and reversibly inhibit 
spermatogenesis in many species including man.[36,37] Histologic 
examination of testicular biopsies from men in these studies 
revealed a complete arrest of spermatogenesis, with an 
absence of forms beyond spermatogonia. Unfortunately, 
subjects taking WIN 18,446 experienced a “disulfiram reaction” 
consisting of nausea, vomiting, and palpitations and sweating, 
when they drank alcohol. Because of this, further development 
of WIN 18,446 was abandoned without an understanding of 
the mechanism by which it inhibited spermatogenesis.
Injectable plugs
Injected plugs were developed in China as a potential 
alternative to vasectomy. The concept is similar to the Intra 
Vas Device, except instead of implanting pre-formed plugs, 
the plugs are injected into the vasa deferentia in liquid form. 
The plugs then harden in place and block the flow of sperm. 
Two different types of injected plugs have been tested: 
medical-grade polyurethane (MPU) and medical-grade silicone 
rubber. Starting in the early 1980s, thousands of Chinese men 
chose MPU plugs as an alternative to vasectomy. Estimates 
of the number of men with plugs range from 13,500 to 
300,000.[38]
Medical-grade polyurethane plugs
MPU plugs have good results in large-scale clinical trials, with 
the largest group of 12,000 men showing 98% azoospermia.[39] 
Unfortunately it takes months for MPU plugs to reach this 
level of effectiveness, with a slow but steady ramping up 
over 18–24 months. A larger trial of 1064 men showed 
68% azoospermia after 6 months, and 98% after 2 years.[40] 
Ninety-eight percent azoospermia was the same rate achieved 
by no-scalpel vasectomy in that trial, proving MPU to be a 
very reliable form of contraception.
Hormonal Male Contraception
Due to the drawbacks of existing methods of male 
contraception, efforts have been made to develop a hormonally 
derived contraceptive analogous to estrogen/progesterone 
birth control pill for women. Surveys conducted in several 
countries suggest that such a hormonally derived male 
contraceptive administered by either daily pills or periodic 
injections would be welcomed by a large percentage of 
men and women,[41] although there are ethnic differences in 
interpreting results of contraceptive trials. Most studies to 
date, however, demonstrate that some men sustain partial 
but incomplete reduction of their sperm counts, a condition 
called oligozoospermia.[42]
Testosterone as contraceptive
This involves hormonal contraceptive regimens with 
longer acting injectable testosterone esters such as 
testosterone enanthate (TE) given by intramuscular 
injection on a weekly to fortnightly basis. Testosterone 
when administered in slightly higher physiologic doses, can 
function as a contraceptive by suppressing the secretion 
of pituitary gonadotropins, luteinizing hormone (LH), 
and FSH. Low levels of LH and FSH deprives the testis 
of the signals required for spermatogenesis, leading 
to markedly decreased sperm counts in most, but not 
in all men. The drawback to TE is that the high-dose 
requirement decreases serum high-density lipoprotein 
cholesterol, which could accelerate atherosclerosis.[43,44] The 
testosterone ester, 7α-methyl-19-nortestosterone which is 
more potent than testosterone[45] and is not converted into 
dihydrotestosterone, the androgen implicated in prostatic 
hypertrophy, acne, and male-pattern baldness could be 
advantageous in the long-term safety and side effect profile 
of a hormonally derived male contraceptive.
Testosterone with progestins
The use of progestin synergistically with testosterone to 
block sperm production has been tested.[46] Studies of 
testosterone and DMPA combinations shows that they 
do induce azoospermia. These combinations shows poor 
contraceptive efficacy. Other newer progestins compounds 
that has been studied are levonorgestrel,[47,48] desogestrel[49] 
and combination of testosterone and levonorgestrel.[26]
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Other Efforts in Male Contraceptives
There are a number of researchers working to describe the 
various chemical pathways required for spermatogenesis. 
Scientists’ understanding of the molecular functioning of 
males’ reproductive tracts is many years behind that of their 
understanding of females’.
Reversible Inhibition of Sperm under Guidance
RISUG is an acronym for Reversible Inhibition of Sperm under 
Guidance and is composed of styrene maleic anhydride 
complexed with the solvent dimethyl sulfoxide.[49] RISUG 
has two contraceptive effects: partial blockage of the vasa 
deferentia and disruption of the sperm that pass through it. 
RISUG is an injectable compound that partially blocks the 
vasa deferentia, providing effective contraception for up to 
10 years per dose. It is effective immediately, has few side 
effects, and has proven to be reversible in primate studies. 
This contraceptive has completed Phase I and II clinical trials 
in India.[50] Sperm that are present in the ejaculate after RISUG 
has been administered have broken cell membranes.[51] The 
membrane carries molecular keys that are needed to attach 
to an egg and packets of enzymes that are needed to dissolve 
the outer coating of an egg. Without those keys or enzymes, 
the sperm is functionally infertile. Researchers postulate 
that RISUG ruptures the membranes by stressing their ion 
exchange mechanisms.[52]
Nifedipine
Nifedipine belongs to a class of drugs known as calcium channel 
blockers and is used as a high blood pressure (hypertension) 
and migraine medication. It also partially block the calcium 
channels within the cell membranes of sperm. This affects 
sperm function rather than production. A man taking 
nifedipine produces a normal amount of sperm, and the 
sperm appears functional when viewed through a microscope, 
but in vitro tests show that these sperm cannot fertilize 
an egg. Research shows that the sperm of men taking 
nifedipine have low levels of mannose lectin on the sperm 
cell membranes.[53] Mannose lectin is a molecule critical for 
binding with an egg’s zona pellucida. Nifedipine treatment 
prevent mannose lectins from moving to the surface of the 
cell membrane by stiffening the membrane with excess 
cholesterol.[53,54]
Retinoic acid receptor antagonist (BMS-189 453)
In the 1980s, researchers at the pharmaceutical company, 
Bristol-Meyers Squibb developed a drug they designated 
BMS-189453 and is a pan-retinoic acid receptor antagonist. 
The drug binds to retinoic acid receptor and prevents it from 
picking up retinoic acid and affects all three known types 
of retinoic acid receptors, namely alpha (α), beta (β), and 
gamma (γ). The unexpected side effect made researchers 
not to study the drug further. It remained on a shelf until a 
group of scientists at Columbia University came knocking in 
2007. Researchers at Columbia University have now shown 
that this drug works as a reversible contraceptive in mice.[34]
Neem extracts (Azadirachta indica)
Neem is a tree with many medicinally valuable parts. Various 
forms of neem have been studied as potential reversible 
male contraceptives. The injection of minute quantities of 
neem oil into the vas deferens has been successfully tested 
as an alternative to surgical vasectomy.[55] Male mice and rats 
fed with fresh neem leaves crushed in water impregnated 
fewer female mice and had smaller average litter sizes.[56] 
Studies of various forms of neem for male contraception 
in different types of mammals have reported no changes in 
libido or hormonal function.[57] In addition, neem bark extract 
and neem seed oil caused arrest of spermatogenesis within 
2 months, with a decrease in the number of Leydig cells that 
is responsible for the manufacturing of testosterone.[58]
Papaya seed extracts (Carica papaya)
The contraceptive qualities of papaya seed extract have been 
known since the early 1970s. When crude extract of papaya 
seeds was fed to male rats, the quantity and quality of the 
sperm they produced deteriorated. At higher doses, this 
provided 100% effective contraception, but it also resulted in 
weight loss, possibly due to toxicity.[59,60] Chloroform extract 
of papaya seeds tested in langur monkeys for 1 year, showed 
a steady decrease in sperm production with no evidence of 
toxicity. Once treatment stopped, full recovery occurred 
within 5 months.
Oleanolic acid
This plant compound is extracted from the flowers of a 
myrtle family tree, Eugenia jambolana studies of oleanolic acid 
in rats show that low, sustained doses result in reversible 
infertility.[61] The studies reported no changes in body weight 
or libido. The compound alters the way sperm pass through 
the epididymis. Normally, immature spermatids are converted 
in the epididymis to fully functioning, motile sperm. The 
sperm of rats treated with oleanolic acid emerged from the 
epididymis with decreased forward motility. Rats treated 
for 30 days became infertile; the contraceptive effect was 
reversed 14 days after ending treatment.[62]
Catsper genes
The cation channels of sperm also known as Catsper 
channels or CatSper are ion channels with four members 
(Catsper 1, 2, 3, and 4) that forms voltage-gated Ca2+ channels 
that seem to be specific to sperm. The Catsper genes encode 
a series of calcium ion exchange channels which occur 
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exclusively in the male reproductive tract. As sperm encounter 
the more alkaline environment of the female reproductive 
tract, Catsper channels become activated by the altered 
ion concentration. These channels are required for proper 
fertilization.[63] Catsper 1 is found in the primary piece of 
sperm and helping in evoking Ca2+ entry and regulation 
of hyperactivation in sperm. Catsper 2 is responsible for 
the regulation of hyperactivation and is in the sperm tail 
while Catsper 3 and Catsper 4 are involved in motility of 
the hyperactivated sperm and are found in the testes and 
sperm. Although Catsper seems to play an important role 
in sperm function, Catspers 1–4 null mice have been found 
to have normal testicular histology, sperm counts, and 
morphology, which is indicative of normal progression of 
spermatogenesis.[64]
Septin 4 gene
Septins are highly conserved in yeast, Drosophila, and mouse 
and belongs to a family of GTP binding proteins required for 
cellular functions such as membrane compartmentalization, 
vesicle trafficking, mitosis, and cytoskeletal remodeling. 
Two of the 14 family members (Septin 12 and 14) in the 
mammalian species are expressed in the testis.[65] In the 
mouse, knockout of Septin 4 and Septin 12 leads to male 
sterility with distinctive sperm pathology i.e., defective 
annulus or bent neck.[66] In humans, sperm with abnormal 
expression pattern of SEPT 4, 7, and 12 are more prevalent in 
infertile men.[67] The gene Septin 4 encodes proteins that help 
sperm to form normal tails. A treated man would produce 
the normal number of sperm; however, their bent tails would 
render them incapable of fertilizing an egg.
Ouabain analogs
Na, K-ATPase α4 is a testis-specific plasma membrane 
Na+ and K+ transporter expressed in sperm flagellum, 
characterized by a high affinity for the cardiac glycoside, 
ouabain. Its selective inhibitor, such as ouabagenin analog 
25, has been found to affect sperm membrane potential, 
intracellular Ca2+, pH, hypermotility, and decrease sperm 
motility both in vitro and in vivo.[67] In addition, deletion of Na, 
K-ATPase α4 in male mice also results in complete infertility, 
making it an attractive target for male contraception.[67]
Conclusion
Additional contraceptives, especially those intended for men, 
are needed to check population growth and prevent undesired 
pregnancy. Existing male methods of contraception, including 
condoms and vasectomy, are effective but have limitations. 
Research has progressed slowly; however, the hormonal 
approach to male contraception is effective, reversible, 
and seems safe. Long-acting injections of testosterone 
esters (e.g. testosterone undecanoate) may prove effective in 
combinations with long-acting progestins. Current research 
is focused on both improving the method and characteristics 
of androgen administration and finding combinations with 
progestins that optimize sperm count suppression in all 
populations while minimizing side effects.
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